Primary Peritoneal Carcinosarcoma: Clinical Trials

3 trials for Primary Peritoneal Carcinosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 2, Completed 1
Phase 21Active not recruiting 1

Follow Primary Peritoneal Carcinosarcoma: new trials by email Literature Review of Primary Peritoneal Carcinosarcoma trials Research Report on Primary Peritoneal Carcinosarcoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma
Phase 1 / Phase 2Active not recruitingMayo Clinic382023-09-282026-09-21
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
Biospecimen Collection, Computed Tomography, Echocardiography Test - Endometrial High Grade Endometrioid Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)552020-05-072026-07-20
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers
Bevacizumab, Laboratory Biomarker Analysis, Nab-paclitaxel - Cervical Adenocarcinoma, Cervical Adenosarcoma
Phase 1CompletedMayo Clinic432014-02-242024-07-26

Narrower conditions

Fallopian Tube Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Neoplasms (1)

Broader conditions

Adnexal Diseases (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Fallopian Tube Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms by Site (2)  ·  Ovarian Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Neoplasms (1)

Interventions

Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Bevacizumab (1)  ·  Biopsy (1)  ·  Blood Component Removal (1)  ·  Disulfides (1)  ·  Doxorubicin (1)  ·  Immunoglobulin G (1)  ·  Taxes (1)  ·  liposomal doxorubicin (1)  ·  pembrolizumab (1)  ·  peposertib (1)

Sponsors

Mayo Clinic (2)  ·  National Cancer Institute (NCI) (1)

Countries

United States (3)

Top investigators

Matthew S. Block, M.D., Ph.D. (1)  ·  Matthew S. Block, MD, PhD (1)  ·  Rachel N Grisham (1)

NIH funding

R01CA276313 (1), UM1CA186691 (1)